Daily Intranasal Oxytocin for Childhood-Onset Schizophrenia
NCT01712646
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
TERMINATED
Status
18
Enrollment
NIH
Sponsor class
Conditions
Childhood Onset Psychotic Disorders
Schizophrenia
Interventions
DRUG:
Intranasal Oxytocin
Sponsor
National Institute of Mental Health (NIMH)